Advances in lipid-based pulmonary nanomedicine for the management of inflammatory lung disorders.

Kumar, Manish; Jha, Abhishek; Bharti, Kanchan; Parmar, Gourav; Mishra, Brahmeshwar

Kumar, Manish; Jha, Abhishek; Bharti, Kanchan; Parmar, Gourav; Mishra, Brahmeshwar.

Afiliação

Kumar M; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, 221005, India.
Jha A; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, 221005, India.
Bharti K; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, 221005, India.
Parmar G; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, 221005, India.
Mishra B; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, 221005, India.

Nanomedicine (Lond) ; 17(12): 913-934, 2022 05.

Article em En | MEDLINE | ID: mdl-35451334

Assuntos

Nanopartículas; Fibrose Pulmonar; Sistemas de Liberação de Medicamentos; Humanos; Lipídeos; Pulmão; Nanomedicina; Nanopartículas/uso terapêutico

Palavras-chave

lipid nanoparticle; liposome; lung inflammation; nanomedicine; pulmonary administration; targeted therapy; therapeutic delivery

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Nanopartículas Limite: Humans Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google